Work Package 5

Development of the Unified Information System

Partners involved: LB, PB4, PB5 and PB6

Deliverable 5.1 Existing Condition Assessment and Necessity – Implementation Study Deliverable 5.2 Supply of required supporting equipment Deliverable 5.3 Implementation of a single Health Insurance File Data Sheet Deliverable 5.4 Development and Publication of printed information material   WP5 concerns the development of the electronic platform consisting of three basic, fully interconnected subsystems. LB is responsible for the creation of the e-Platform. Its development will be implemented in four stages that are analyzed as follows: System Implementation phases Α1.1 PHASE 1 – Existing Condition Assessment and Necessity – Implementation Study A1.2 PHASE 2 – Supply of required supporting equipment Α1.3 PHASE 3 – Implementation of a single Health Insurance File Data Sheet A1.4 PHASE 4 – Development and Publication of printed information material The e-Platform has several advantages, such as:

1. Added value in the existing Health Insurance File by enriching data from other countries (hospital information, medication, diagnostic test results, etc.)
2. Possibility of statistical reports relating to cross-border care
3. The cooperation of Greece with North Macedonia can act as a “pilot” project, which then spreads to other countries

The Ministry of Health has established a national E- health system called “Moj termin”, which is implemented and used in all health institutions and institutions from all segments of health care. However, the newly created e-Platform should be compatible with the national system Moj termin. Thus, the personnel working in the E-health directorate will meet with the experts engaged in the development of the platform in order to be informed on its architecture, technical and functional characteristics, and all distinct parts of this information system. Additionally, they will provide relevant data needed to the consultants on the national E health system (involvement of PB4, PB5 and PB6).